209 related articles for article (PubMed ID: 32980446)
1. Generation of a reporter yellow fever virus for high throughput antiviral assays.
Sanchez-Velazquez R; de Lorenzo G; Tandavanitj R; Setthapramote C; Bredenbeek PJ; Bozzacco L; MacDonald MR; Clark JJ; Rice CM; Patel AH; Kohl A; Varjak M
Antiviral Res; 2020 Nov; 183():104939. PubMed ID: 32980446
[TBL] [Abstract][Full Text] [Related]
2. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
[TBL] [Abstract][Full Text] [Related]
3. Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D.
Li D; Ye JL; Liu ZY
Virol Sin; 2021 Dec; 36(6):1456-1464. PubMed ID: 34342842
[TBL] [Abstract][Full Text] [Related]
4. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
[TBL] [Abstract][Full Text] [Related]
5. Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay.
Patkar CG; Larsen M; Owston M; Smith JL; Kuhn RJ
Antimicrob Agents Chemother; 2009 Oct; 53(10):4103-14. PubMed ID: 19651907
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
[TBL] [Abstract][Full Text] [Related]
7. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
[TBL] [Abstract][Full Text] [Related]
8. Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus.
Dong HL; Wang HJ; Liu ZY; Ye Q; Qin XL; Li D; Deng YQ; Jiang T; Li XF; Qin CF
Emerg Microbes Infect; 2021 Dec; 10(1):1739-1750. PubMed ID: 34379047
[TBL] [Abstract][Full Text] [Related]
9. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
[TBL] [Abstract][Full Text] [Related]
10. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
[TBL] [Abstract][Full Text] [Related]
11. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
[TBL] [Abstract][Full Text] [Related]
12. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
13. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
14. A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.
Thibodeaux BA; Garbino NC; Liss NM; Piper J; Schlesinger JJ; Blair CD; Roehrig JT
Antiviral Res; 2012 Apr; 94(1):1-8. PubMed ID: 22366350
[TBL] [Abstract][Full Text] [Related]
15. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.
Neyts J; Meerbach A; McKenna P; De Clercq E
Antiviral Res; 1996 May; 30(2-3):125-32. PubMed ID: 8783804
[TBL] [Abstract][Full Text] [Related]
16. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
[TBL] [Abstract][Full Text] [Related]
18. Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti.
Danet L; Beauclair G; Berthet M; Moratorio G; Gracias S; Tangy F; Choumet V; Jouvenet N
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007299. PubMed ID: 31412040
[TBL] [Abstract][Full Text] [Related]
19. Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus.
Pacca CC; Marques RE; Espindola JWP; Filho GBOO; Leite ACL; Teixeira MM; Nogueira ML
Biomed Pharmacother; 2017 Mar; 87():381-387. PubMed ID: 28068627
[TBL] [Abstract][Full Text] [Related]
20. A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating.
Ramanathan HN; Zhang S; Douam F; Mar KB; Chang J; Yang PL; Schoggins JW; Ploss A; Lindenbach BD
mBio; 2020 Apr; 11(2):. PubMed ID: 32291299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
